CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
CERVISEG-300-I Study	2011-05-17	Registered
Clinical Trial Heberbiovac HB vaccine Material Reference Batch	2011-05-16	Registered
NASVAC therapeutic vaccine study	2011-05-16	Registered
Heberprovac Study	2011-05-16	Registered
TS-FARMEV Study	2011-05-16	Registered
GrUVen-I Study	2011-05-03	Registered
EGFpeeling I	2011-05-03	Registered
NEUVITAL V Study	2011-04-30	Registered
Change in Manufacture Process of Heberbiovac HB vaccine.	2011-04-30	Registered
CENTAURO Study	2011-04-29	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.	2011-04-29	Registered
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study.	2011-04-28	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks.	2011-04-27	Registered
InCarbacel-II	2010-12-28	Registered
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed	2010-12-27	Registered
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers.	2010-12-24	Registered
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2).	2010-12-24	Registered
InCCNM -I	2010-12-24	Registered
Application of CIGB-128 in keloid patients undergoing surgical exeresis.	2010-12-24	Registered
CIGB-128 administration to patients with surgically-treated keloids.	2010-12-24	Registered